-
1
-
-
0442268112
-
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team
-
Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997; 337:725-733.
-
(1997)
N Engl J Med
, vol.337
, pp. 725-733
-
-
Hammer, S.M.1
Squires, K.E.2
Hughes, M.D.3
-
2
-
-
6844240219
-
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
-
The Advanced HIV Disease Ritonavir Study Group
-
Cameron DW, Heath-Chiozzi M, Danner S, et al. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet 1998; 351:543-549.
-
(1998)
Lancet
, vol.351
, pp. 543-549
-
-
Cameron, D.W.1
Heath-Chiozzi, M.2
Danner, S.3
-
3
-
-
0035965633
-
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy
-
Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. J Am Med Assoc 2001; 286:2568-2577.
-
(2001)
J Am Med Assoc
, vol.286
, pp. 2568-2577
-
-
Hogg, R.S.1
Yip, B.2
Chan, K.J.3
-
4
-
-
0037072066
-
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies
-
Egger M, May M, Chêne G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360:119-129.
-
(2002)
Lancet
, vol.360
, pp. 119-129
-
-
Egger, M.1
May, M.2
Chêne, G.3
-
6
-
-
4444227111
-
Mortality in HIV-seropositive- Verus seronegative persons in the era of highly active antiretroviral therapy: Implications for when to initiate therapy
-
Wang C, Vlahov D, Galai N, et al. Mortality in HIV-seropositive- verus seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J Infect Dis 2004; 190:1046-1054.
-
(2004)
J Infect Dis
, vol.190
, pp. 1046-1054
-
-
Wang, C.1
Vlahov, D.2
Galai, N.3
-
8
-
-
2542452668
-
-
Rockville: A Service of the U.S Department of Health and Human Services; October 6
-
AIDSinfo [homepage on the Internet]. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Rockville: A Service of the U.S Department of Health and Human Services; 2005 October 6. Available from: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
-
(2005)
Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents
-
-
-
10
-
-
3042726798
-
Treatment for adult HIV infection. 2004 recommendations of the international AIDS society-USA panel
-
Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection. 2004 recommendations of the international AIDS society-USA panel. J Am Med Assoc 2004; 292:251-265.
-
(2004)
J Am Med Assoc
, vol.292
, pp. 251-265
-
-
Yeni, P.G.1
Hammer, S.M.2
Hirsch, M.S.3
-
11
-
-
0035944786
-
Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: Observational study
-
Devereaux PJ, Anderson DR, Gardner MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. Br Med J 2001; 323:1-7.
-
(2001)
Br Med J
, vol.323
, pp. 1-7
-
-
Devereaux, P.J.1
Anderson, D.R.2
Gardner, M.J.3
-
12
-
-
0034843354
-
How do patients' treatment preferences compare with those of clinicians?
-
Montgomery AA, Fahey T. How do patients' treatment preferences compare with those of clinicians? Qual Health Care 2001; 10:39-43.
-
(2001)
Qual Health Care
, vol.10
, pp. 39-43
-
-
Montgomery, A.A.1
Fahey, T.2
-
13
-
-
0031717679
-
Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate
-
Nieuwkerk PT, Hajenius PJ, Van der Veen F, Ankum WM, Wijker W, Bossuyt PM. Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate. Fertil Steril 1998; 70:518-522.
-
(1998)
Fertil Steril
, vol.70
, pp. 518-522
-
-
Nieuwkerk, P.T.1
Hajenius, P.J.2
Van Der Veen, F.3
Ankum, W.M.4
Wijker, W.5
Bossuyt, P.M.6
-
14
-
-
0031015328
-
Trading treatment toxicity for survival in locally advanced non-small cell lung cancer
-
Brundage MD, Davidson JR, Mackillop WJ. Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol 1997; 15:330-340.
-
(1997)
J Clin Oncol
, vol.15
, pp. 330-340
-
-
Brundage, M.D.1
Davidson, J.R.2
Mackillop, W.J.3
-
15
-
-
0029813715
-
Warfarin for atrial fibrillation. The patient's perspective
-
Man-Son-Hing M, Laupacis A, O Connor A, et al. Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med 1996; 156:1841-1848.
-
(1996)
Arch Intern Med
, vol.156
, pp. 1841-1848
-
-
Man-Son-Hing, M.1
Laupacis, A.2
O Connor, A.3
-
16
-
-
33744759053
-
-
ART cohort collaboration [homepage on the internet]. ART cohort collaboration [updated 13 June; cited 28 November 2004]
-
ART cohort collaboration [homepage on the internet]. ART cohort collaboration [updated 13 June 2005; cited 28 November 2004] Available from: http://www.art-cohort-collaboration.org.
-
(2005)
-
-
-
17
-
-
0345269688
-
Prediction of residual time to AIDS and death based on markers and cofactors
-
Geskus RB, Miedema FA, Goudsmit J, Reiss P, Schuitemaker H, Coutinho RA. Prediction of residual time to AIDS and death based on markers and cofactors. J Acquir Immune Defic Syndr 2003; 32:514-521.
-
(2003)
J Acquir Immune Defic Syndr
, vol.32
, pp. 514-521
-
-
Geskus, R.B.1
Miedema, F.A.2
Goudsmit, J.3
Reiss, P.4
Schuitemaker, H.5
Coutinho, R.A.6
-
18
-
-
0030666187
-
The role of numeracy in understanding the benfit of screening mammography
-
Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benfit of screening mammography. Ann Intern Med 1997; 127:966-972.
-
(1997)
Ann Intern Med
, vol.127
, pp. 966-972
-
-
Schwartz, L.M.1
Woloshin, S.2
Black, W.C.3
Welch, H.G.4
-
19
-
-
0035659080
-
'I will start treatment when I think the time is right': HIV-positive gay men talk about their decision not to access antiretroviral therapy
-
Gold RS, Ridge DT. 'I will start treatment when I think the time is right': HIV-positive gay men talk about their decision not to access antiretroviral therapy. AIDS Care 2001; 13:693-708.
-
(2001)
AIDS Care
, vol.13
, pp. 693-708
-
-
Gold, R.S.1
Ridge, D.T.2
-
20
-
-
0036273470
-
Perceptions of HAART among gay men who declined a treatment offer: Preliminary results from an interview-based study
-
Cooper V, Buick D, Horne R, et al. Perceptions of HAART among gay men who declined a treatment offer: preliminary results from an interview-based study. AIDS Care 2002; 14:319-328.
-
(2002)
AIDS Care
, vol.14
, pp. 319-328
-
-
Cooper, V.1
Buick, D.2
Horne, R.3
-
21
-
-
4143110373
-
Review of determinants of patients' preferences for adjuvant therapy in cancer
-
Jansen SJT, Otten W, Stiggelbout AM. Review of determinants of patients' preferences for adjuvant therapy in cancer. J Clin Oncol 2004; 22:3181-3190.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3181-3190
-
-
Jansen, S.J.T.1
Otten, W.2
Stiggelbout, A.M.3
-
22
-
-
0028307292
-
Incorporating patients' preferences into medical decisions
-
Kassirer JP. Incorporating patients' preferences into medical decisions. N Engl J Med 1994; 330:1895-1896.
-
(1994)
N Engl J Med
, vol.330
, pp. 1895-1896
-
-
Kassirer, J.P.1
-
23
-
-
0031708733
-
Cognitive dissonance. 1: An overview of the literature and its integration into theory and practice in clinical psychology
-
Draycott S, Dabbs A. Cognitive dissonance. 1: An overview of the literature and its integration into theory and practice in clinical psychology. Br J Clin Psychol 1998; 37:341-353.
-
(1998)
Br J Clin Psychol
, vol.37
, pp. 341-353
-
-
Draycott, S.1
Dabbs, A.2
-
24
-
-
0035894169
-
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection
-
Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001; 28:445-449.
-
(2001)
J Acquir Immune Defic Syndr
, vol.28
, pp. 445-449
-
-
Ammassari, A.1
Murri, R.2
Pezzotti, P.3
-
25
-
-
0037192573
-
Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy
-
Dieleman JP, Jambroes M, Gyssens IC, et al. Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. AIDS 2002; 16:737-745.
-
(2002)
AIDS
, vol.16
, pp. 737-745
-
-
Dieleman, J.P.1
Jambroes, M.2
Gyssens, I.C.3
|